Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

204.89 USD +1.07 (+0.52%)
Official Closing Price Updated: 7:56 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,887,800
Open 206.70
Bid (Size) 204.95 (1)
Ask (Size) 205.29 (3)
Prev. Close 203.82
Today's Range 202.06 - 206.99
52wk Range 117.06 - 218.00
Shares Outstanding 1,085,430,420
Dividend Yield 1.10%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Lilly announces additional doses of neutralizing antibody therapy purchased by U.S. government to treat COVID-19
The U.S. government has agreed to purchase a minimum of 100,000 doses of bamlanivimab (LY-CoV555) 700 mg and etesevimab (LY-CoV016) 1400 mg together, Eli Lilly and Company (NYSE: LLY) announced.... 
From PR Newswire
U.S. Government to Purchase Minimum of 100,000 Doses of Etesevimab and Bamlanivimab Neutralizing Antibody Therapy
From GlobeNewswire News Releases

Performance

YTD
+23.80%
+23.80%
1 Month
-1.29%
-1.29%
3 Month
+38.97%
+38.97%
6 Month
+39.06%
+39.06%
1 Year
+58.60%
+58.60%

More News

Read More
Welldoc and Lilly collaborate to integrate BlueStar® app capabilities into Lilly's connected insulin solutions
From PR Newswire
Lilly to Participate in Cowen Health Care Conference
From PR Newswire
Are These Top Health Care Stocks Worth Watching Ahead Of March?
Tags Market News
From Stockmarket.com
US Government Calls For Additional Eli Lilly COVID-19 Antibody Therapy
Tags Benzinga LLY General
From Benzinga
Global COVID cases top 113 million as FDA committee meets to vote on J&J vaccine
Tags JNJ LLY ONEM
From MarketWatch
Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning
From Investor's Business Daily
RLFTF: Why Little-Known Relief Therapeutics Is Climbing Today
Tags Market News PFE AIM
From InvestorPlace
Veru Files US Application For TADFIN Combo For Prostate Enlargement
Tags VERU Biotech MRK
From Benzinga
Precision Bio's ARCUS Gene Editing Platform Is Safe, Durable; Long-Term Animal Study Shows
Tags LLY General DTIL
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.